Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Change in Accured Expenses: 2021-2025

Historic Change in Accured Expenses for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to $34.7 million.

  • Core Scientific's Change in Accured Expenses rose 2409.47% to $34.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.7 million, marking a year-over-year decrease of 1.13%. This contributed to the annual value of $1.9 million for FY2024, which is 98.56% down from last year.
  • According to the latest figures from Q3 2025, Core Scientific's Change in Accured Expenses is $34.7 million, which was up 377.76% from -$12.5 million recorded in Q2 2025.
  • Core Scientific's Change in Accured Expenses' 5-year high stood at $117.4 million during Q4 2023, with a 5-year trough of -$35.9 million in Q2 2024.
  • Over the past 3 years, Core Scientific's median Change in Accured Expenses value was $1.4 million (recorded in 2024), while the average stood at $14.3 million.
  • As far as peak fluctuations go, Core Scientific's Change in Accured Expenses plummeted by 1,042.49% in 2024, and later skyrocketed by 2,409.47% in 2025.
  • Quarterly analysis of 5 years shows Core Scientific's Change in Accured Expenses stood at $38.3 million in 2021, then tumbled by 54.33% to $17.5 million in 2022, then spiked by 571.90% to $117.4 million in 2023, then tumbled by 60.17% to $46.8 million in 2024, then skyrocketed by 2,409.47% to $34.7 million in 2025.
  • Its Change in Accured Expenses stands at $34.7 million for Q3 2025, versus -$12.5 million for Q2 2025 and $2.7 million for Q1 2025.